Panagora Asset Management Inc Adma Biologics, Inc. Transaction History

Panagora Asset Management Inc

  • $21 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$1.13 - $1.65 $1,117 - $1,631
-989 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$1.51 - $2.07 $190 - $260
-126 Reduced 11.3%
989 $2,000
Q4 2020

Feb 10, 2021
BUY
$1.8 - $2.56 $2,007 - $2,854
1,115 New
1,115 $2,000
Q2 2020

Aug 12, 2020
SELL
$2.42 - $3.29 $130,171 - $176,969
-53,790 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$1.5 - $4.59 $80,685 - $246,896
53,790 New
53,790 $155,000

Others Institutions Holding ADMA

# of Institutions
339
Shares Held
182M
Call Options Held
1.72M
Put Options Held
846K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.05B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email